Status:
COMPLETED
Understanding and Modeling Reservoirs, Vehicles and Transmission of ESBL-producing Enterobacteriaceae in the Community and Long Term Care Facilities
Lead Sponsor:
Centre Hospitalier Universitaire de Besancon
Collaborating Sponsors:
Hospital Universitario Virgen Macarena
University Hospital Tuebingen
Conditions:
Resistance Bacterial
Enterobacteriaceae Infections
Eligibility:
All Genders
Brief Summary
The continuing spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) is among the most important problems in antimicrobial resistance. It is also a good model to investigat...
Eligibility Criteria
Inclusion
- Residents of the Bellevaux LTCF (Besançon - France)
- Patients discharged from the University Hospital of Besançon and carrying ESBL-E. coli or K. pneumoniae and their household members
Exclusion
- Participation rejection
Key Trial Info
Start Date :
March 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 29 2020
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT03477084
Start Date
March 1 2017
End Date
February 29 2020
Last Update
March 10 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital
Besançon, Bourgogne-Franche-Comté, France, 25030